Skip to main content
File #: 21-734    Version: 1 Name: RESOLUTION of the City of San Leandro City Council approving and authorizing to Participate and Receive Settlement Funds Derived From Multi-District Litigation in Cooperation with the California Attorney General
Type: Resolution - Council Status: Passed
In control: City Council
Meeting Date: 12/13/2021 Final action: 12/13/2021
Enactment date: 12/13/2021 Enactment #: Reso 2021-178
Title: RESOLUTION of the City of San Leandro City Council approving and authorizing the City of San Leandro to enter into Settlement Agreements with McKesson Corporation, Cardinal Health, Inc. Amerisource Bergen Corporation, Johnson & Johnson, Janssen Pharmaceuticals, Inc. Orhto-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceuticals, Inc. to Participate and Receive Settlement Funds Derived From Multi-District Litigation in Cooperation with the California Attorney General
Related files: 21-733
Title
RESOLUTION of the City of San Leandro City Council approving and authorizing the City of San Leandro to enter into Settlement Agreements with McKesson Corporation, Cardinal Health, Inc. Amerisource Bergen Corporation, Johnson & Johnson, Janssen Pharmaceuticals, Inc. Orhto-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceuticals, Inc. to Participate and Receive Settlement Funds Derived From Multi-District Litigation in Cooperation with the California Attorney General

Body
WHEREAS, the United States is facing an ongoing public health crisis of opioid abuse, addiction, overdose, and death. The State of California and California local governments spend millions of dollars each year to address the direct consequences of this crisis; and

WHEREAS, since 2017, state and local governments in California and around the United States have been pursuing litigation against certain manufacturers, distributors, and retailers of opioid pharmaceuticals (the "Opioid Defendants") in an effort to hold the Opioid Defendants financially responsible for the impact of the Opioid Epidemic; and

WHEREAS, negotiations to settle claims against several of the Opioid Defendants, specifically McKesson Corporation, Cardinal Health, Inc., AmerisourceBergen Corporation, Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutical, Inc. (the "Settling Defendants") have been ongoing for several years; and

WHEREAS, negotiations with the Settling Defendants have resulted in proposed nationwide settlements of state and local government claims to settle the litigation; and

WHEREAS, the proposed terms of those proposed nationwide settlements have been set forth in the Distributors Master Settlement Agreement and the J&J Master Settlement Agreement (collectively "Settlement Agreements"); and

WHEREAS, the Settlement Agreements provide, among other things, for the payme...

Click here for full text